Who
David Kupfer
Director
Company insider
Files Form 4 as: Director, Minerva Neurosciences.
In numbers
- Trades disclosed
- 18
- Buys
- 4
- Sells
- 1
- Bought
- $1.7M
- Sold
- $49K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 2 Nov 2015
- Last trade
- 3 Jun 2026
- Last filed
- 5 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 5 Jun 2026 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 22 Dec 2025filed 23 Dec 2025 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 5 Dec 2024filed 6 Dec 2024 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 27 Sep 2023filed 29 Sep 2023 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 10 Jun 2022filed 28 Jun 2022 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,500 at $0.00 | filing |
| 1 Dec 2021filed 3 Dec 2021 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Sold | $49K55,635 at $0.88 | filing |
| 11 Jun 2021filed 15 Jun 2021 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 11 Jun 2020filed 12 Jun 2020 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 26 Jun 2019filed 27 Jun 2019 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Bought | $56K10,000 at $5.55 | filing |
| 31 May 2019filed 31 May 2019 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 7 Jun 2018filed 11 Jun 2018 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 1 Jun 2017filed 5 Jun 2017 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 21 Jun 2016filed 21 Jun 2016 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Bought | $300K27,935 at $10.73 | filing |
| 20 Jun 2016filed 21 Jun 2016 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Bought | $303K27,700 at $10.95 | filing |
| 16 Jun 2016filed 17 Jun 2016 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 17 Mar 2016filed 18 Mar 2016 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Bought | $1000K181,488 at $5.51 | filing |
| 2 Nov 2015filed 3 Nov 2015 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.